PACIRA BIOSCIENCES, INC. Variable Lease, Cost
PACIRA BIOSCIENCES, INC. (PCRX) reported Variable Lease, Cost of $620.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-04
- PACIRA BIOSCIENCES, INC. variable lease, cost for the quarter ending 2026-06-30 was $620.00K, a 7.64% increase year-over-year.
- PACIRA BIOSCIENCES, INC. variable lease, cost for the quarter ending 2026-03-31 was $560.00K, a 3.90% increase year-over-year.
- PACIRA BIOSCIENCES, INC. variable lease, cost for the quarter ending 2025-12-31 was $542.00K, a 0.37% decline year-over-year.
- PACIRA BIOSCIENCES, INC. variable lease, cost for the quarter ending 2025-09-30 was $642.00K, a 14.23% increase year-over-year.
- PACIRA BIOSCIENCES, INC. variable lease, cost for fiscal 2025 was $2.30M, a 21.70% increase from fiscal 2024.
- PACIRA BIOSCIENCES, INC. variable lease, cost for fiscal 2024 was $1.89M, a 3.23% decline from fiscal 2023.
- PACIRA BIOSCIENCES, INC. variable lease, cost for fiscal 2023 was $1.95M, a 1.81% decline from fiscal 2022.
- PACIRA BIOSCIENCES, INC. variable lease, cost for fiscal 2022 was $1.99M, a 15.45% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $620.00K 10-Q · filed 2026-08-04 | $1.18M 10-Q · filed 2026-08-04 | $1.72M derived: sum of 3 quarters · filed 2026-08-04 | $2.36M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $560.00K 10-Q · filed 2026-04-30 | $1.10M derived: sum of 2 quarters · filed 2026-04-30 | $1.74M derived: sum of 3 quarters · filed 2026-04-30 | $2.32M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $542.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.18M derived: sum of 2 quarters · filed 2026-02-26 | $1.76M derived: sum of 3 quarters · filed 2026-08-04 | $2.30M 10-K · filed 2026-02-26 |
| 2025-09-30 | $642.00K 10-Q · filed 2025-11-06 | $1.22M derived: sum of 2 quarters · filed 2026-08-04 | $1.76M 10-Q · filed 2025-11-06 | $2.30M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $576.00K 10-Q · filed 2026-08-04 | $1.11M 10-Q · filed 2026-08-04 | $1.66M derived: sum of 3 quarters · filed 2026-08-04 | $2.22M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $539.00K 10-Q · filed 2026-04-30 | $1.08M derived: sum of 2 quarters · filed 2026-04-30 | $1.65M derived: sum of 3 quarters · filed 2026-04-30 | $1.93M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $544.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.11M derived: sum of 2 quarters · filed 2026-02-26 | $1.40M derived: sum of 3 quarters · filed 2026-02-26 | $1.89M 10-K · filed 2026-02-26 |
| 2024-09-30 | $562.00K 10-Q · filed 2025-11-06 | $851.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.34M 10-Q · filed 2025-11-06 | $1.85M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $289.00K 10-Q · filed 2025-08-05 | $783.00K 10-Q · filed 2025-08-05 | $1.29M derived: sum of 3 quarters · filed 2026-02-26 | $1.79M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $494.00K 10-Q · filed 2025-05-08 | $1.00M derived: sum of 2 quarters · filed 2026-02-26 | $1.50M derived: sum of 3 quarters · filed 2026-02-26 | $1.88M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $508.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.01M derived: sum of 2 quarters · filed 2026-02-26 | $1.39M derived: sum of 3 quarters · filed 2026-02-26 | $1.95M 10-K · filed 2026-02-26 |
| 2023-09-30 | $499.00K 10-Q · filed 2024-11-06 | $877.00K derived: sum of 2 quarters · filed 2024-11-06 | $1.44M 10-Q · filed 2024-11-06 | $1.91M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $378.00K 10-Q · filed 2024-07-30 | $945.00K 10-Q · filed 2024-07-30 | $1.41M derived: sum of 3 quarters · filed 2025-02-27 | $1.95M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $567.00K 10-Q · filed 2024-05-07 | $1.03M derived: sum of 2 quarters · filed 2025-02-27 | $1.57M derived: sum of 3 quarters · filed 2025-02-27 | $2.08M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $468.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.01M derived: sum of 2 quarters · filed 2025-02-27 | $1.52M derived: sum of 3 quarters · filed 2025-02-27 | $1.99M 10-K · filed 2025-02-27 |
| 2022-09-30 | $540.00K 10-Q · filed 2023-11-02 | $1.05M derived: sum of 2 quarters · filed 2023-11-02 | $1.52M 10-Q · filed 2023-11-02 | $1.92M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $508.00K 10-Q · filed 2023-08-02 | $980.00K 10-Q · filed 2023-08-02 | $1.38M derived: sum of 3 quarters · filed 2024-02-29 | $1.80M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $472.00K 10-Q · filed 2023-05-03 | $876.00K derived: sum of 2 quarters · filed 2024-02-29 | $1.29M derived: sum of 3 quarters · filed 2024-02-29 | $1.72M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $404.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $820.00K derived: sum of 2 quarters · filed 2024-02-29 | $1.24M derived: sum of 3 quarters · filed 2024-02-29 | $1.72M 10-K · filed 2024-02-29 |
| 2021-09-30 | $416.00K 10-Q · filed 2022-11-03 | $840.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.32M 10-Q · filed 2022-11-03 | $1.75M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $424.00K 10-Q · filed 2022-08-03 | $902.00K 10-Q · filed 2022-08-03 | $1.34M derived: sum of 3 quarters · filed 2023-02-28 | $1.95M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $478.00K 10-Q · filed 2022-05-04 | $913.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.52M derived: sum of 3 quarters · filed 2023-02-28 | $2.13M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $435.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.05M derived: sum of 2 quarters · filed 2023-02-28 | $1.65M derived: sum of 3 quarters · filed 2023-02-28 | $2.10M 10-K · filed 2023-02-28 |
| 2020-09-30 | $611.00K 10-Q · filed 2021-11-03 | $1.21M derived: sum of 2 quarters · filed 2021-11-03 | $1.66M 10-Q · filed 2021-11-03 | $2.08M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $601.00K 10-Q · filed 2021-08-03 | $1.05M 10-Q · filed 2021-08-03 | $1.47M derived: sum of 3 quarters · filed 2022-02-28 | $1.87M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $448.00K 10-Q · filed 2021-05-04 | $866.00K derived: sum of 2 quarters · filed 2022-02-28 | $1.27M derived: sum of 3 quarters · filed 2022-02-28 | $1.72M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $418.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $821.00K derived: sum of 2 quarters · filed 2022-02-28 | $1.27M derived: sum of 3 quarters · filed 2022-02-28 | $1.65M 10-K · filed 2022-02-28 |
| 2019-09-30 | $403.00K 10-Q · filed 2020-10-30 | $852.00K derived: sum of 2 quarters · filed 2020-10-30 | $1.23M 10-Q · filed 2020-10-30 | $1.69M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $449.00K 10-Q · filed 2020-08-06 | $829.00K 10-Q · filed 2020-08-06 | $1.29M derived: sum of 3 quarters · filed 2021-03-01 | $1.78M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $381.00K 10-Q · filed 2020-05-07 | $837.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.33M derived: sum of 3 quarters · filed 2021-03-01 | $1.74M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $456.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $951.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.36M derived: sum of 3 quarters · filed 2021-03-01 | $1.76M 10-K · filed 2021-03-01 |
| 2018-09-30 | $495.00K 10-Q · filed 2019-11-08 | $903.00K derived: sum of 2 quarters · filed 2019-11-08 | $1.30M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $408.00K 10-Q · filed 2019-08-08 | $810.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $402.00K 10-Q · filed 2019-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |